9,421 followers
Brentuximab vedotin demonstrates objective responses in a phase 2 study of r/r #DLBCL with variable CD30 expression. http://t.co/n8ZRR0Zzop
Brentuximab vedotin demonstrates objective responses in a phase 2 study of r/r #DLBCL with variable CD30 expression. http://t.co/n8ZRR0Zzop
Responses with Brentuximab in a ph 2 study of rel/refr DLBCL. No correl with level of CD30, just need some CD30. http://t.co/ngVNndAYi1
Responses with Brentuximab in a ph 2 study of rel/refr DLBCL. No correl with level of CD30, just need some CD30. http://t.co/ngVNndAYi1
Responses with Brentuximab in a ph 2 study of rel/refr DLBCL. No correl with level of CD30, just need some CD30. http://t.co/ngVNndAYi1